Literature DB >> 15327490

Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.

Ashraf Nour1.   

Abstract

Sentinel lymph node biopsy (SLNB) is an important surgical advance in the management of early breast cancer. Localization of the sentinel lymph node (SLN) in breast cancer and other cancer patients is widely used now utilizing isosulfan blue dye. Few alternative types of dye have been used and investigated. In a prospective study of 54 patients, methylene blue dye was used as an alternative to isosulfan blue to localize the SLN in breast cancer patients. The methylene blue dye technique was successful in 91.1% of patients after excluding the initial learning cases; the results are similar for isosulfan blue dye. This study describes methylene blue dye localization as a successful alternative to isosulfan blue dye in identifying the sentinel node in breast cancer patients. Methylene blue dye is readily available in most Egyptian institutes, with a very low cost.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327490     DOI: 10.1111/j.1075-122X.2004.21360.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  14 in total

1.  Adverse effects of dyes used in sentinel node biopsy on immunocytochemical determination of hormone receptors in breast cancer cells.

Authors:  Y A Masannat; A M Shaaban; V Speirs; G Coast; P Jackson; K Horgan; A M Hanby
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

2.  Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

Authors:  Altan Özdemir; Burhan Mayir; Kenan Demirbakan; Nezihi Oygür
Journal:  J Breast Health       Date:  2014-04-01

3.  Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear Technology.

Authors:  Mahmoud A Alhussini; Ahmed T Awad; Mohamed H Ashour; Ahmed Abdelateef; Haytham Fayed
Journal:  Breast Care (Basel)       Date:  2016-08-15       Impact factor: 2.860

4.  Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability and Clinical Relevance in a Non-screened Population.

Authors:  Sanjit Kumar Agrawal; Sachin Suresh Shenoy; Nikhil Nalawade; Soumtira Shankar Datta; Soumendranath Roy; Sanjoy Chatterjee; Indu Arun; Rosina Ahmed
Journal:  Indian J Surg Oncol       Date:  2017-08-21

5.  Tc-99m diphosphonate as a potential radiotracer to detect sentinel lymph nodes in patients with breast cancer.

Authors:  You-Jung Yang; Sung-Jig Lim; Jeong-Yoon Song
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

6.  The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.

Authors:  Sarah Pesek; Taka Ashikaga; Lars Erik Krag; David Krag
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

7.  Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.

Authors:  S P Somashekhar; S Zaveri Shabber; K Udupa Venkatesh; K Venkatachala; M M Vasan Thirumalai
Journal:  Indian J Surg       Date:  2008-07-24       Impact factor: 0.656

8.  The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.

Authors:  Bayu Brahma; Rizky Ifandriani Putri; Ramadhan Karsono; Bob Andinata; Walta Gautama; Lenny Sari; Samuel J Haryono
Journal:  World J Surg Oncol       Date:  2017-02-07       Impact factor: 2.754

Review 9.  Recent Developments of ICG-Guided Sentinel Lymph Node Mapping in Oral Cancer.

Authors:  Ji-Hoon Kim; Minhee Ku; Jaemoon Yang; Hyung Kwon Byeon
Journal:  Diagnostics (Basel)       Date:  2021-05-17

10.  Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.

Authors:  Jeffrey M East; Christopher S P Valentine; Emil Kanchev; Garfield O Blake
Journal:  BMC Surg       Date:  2009-01-27       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.